The discontinuation rate due to side effects was 6.1% for Zepbound and 8% for ... saying it would align US drug prices with ...

An assessment by UBS says Bristol Myers Squibb and Pfizer would be worst hit among US companies if Mr Trump’s threatened ...

US President Donald Trump has signed an executive order that aims to reduce high prescription drug prices – but its details ...

US drug prices are up to five times higher than in other developed nations. Trump's order requires US drug prices to align ...

The county joins municipalities across the country suing Eli Lilly, CVS Caremark, and others for sky-high prices.

Novo Nordisk and Eli Lilly , the leaders in the highly lucrative ... Roche says Trump's drug price order threatens its $50 billion US investment plans U.S. President Donald Trump's executive ...

European pharma leaders push for higher drug prices to boost global competitiveness. 2. CEOs warn EU may lose out on ...

Looking at surging obesity drug sales, market share momentum, and an increased fair value estimate, here’s what we think of ...

CVS Caremark decided to stop offering Zepbound in favor of Wegovy for weight loss. It’s the latest example of limits imposed ...

A bold move by US President Donald Trump to slash the cost of prescription drugs in America has sent shockwaves through the ...

This sharp decline comes amid broader market volatility and specific concerns in the healthcare sector, particularly related to pricing pressures and regulatory scrutiny surrounding weight-loss drugs, ...

Novo Nordisk has replaced CEO Lars Fruergaard Jorgensen amid competitive pressures in the obesity drug market. His exit comes ...